| Overview |
| bsm-90170R |
| ATP7B Recombinant Antbody Kit (KD-Validated) |
| WB, FCM, IC |
| Knockdown Validated |
| Human |
| Specifications |
| Unconjugated |
| Rabbit |
| A synthesized peptide derived from human ATP7b |
| 1400-1465/1465 |
| Monoclonal |
| IgG |
| Lot dependent |
| Affinity Purified |
| 0.01M TBS (pH 7.4), 1% BSA, 0.02% Proclin 300, and 50% Glycerol |
| -20 °C |
| Target |
| 540 |
| P35670 |
| ATP7B; ATPase Copper Transporting Beta; Copper-Transporting ATPase 2; Copper Pump 2; WND; ATPase Cu++ Transporting Beta Polypeptide; Wilson Disease-Associated Protein; PWD; WC1; ATPase Cu++ Transporting Beta Polypeptide (Wilson Disease); ATPase Cu(2+)- Transporting Beta Polypeptide; Copper-Transporting Protein ATP7B; Wilson Disease; EC 7.2.2.8; EC 3.6.3.4; EC 3.6.3; WD |
| Cell Line: HT-1080 Knockdown technology: shRNA Knockdown |
| Application Dilution |
| WB |
1:300-5000 |
| FCM |
1:20-100 |
| IC |
1:1000 |
Powered by Bioz